This 23-gene genomic test comprises 20 breast cancer recurrence-related genes with three housekeeping genes and six clinical factors (the age at first diagnosis, the nodal stage, the tumor grading, the tumor size, the estrogen receptor (ER) status, and the lymphovascular invasion (LVI) status) [12]. Here, ESR1 is linked to breast carcinoma.